Back to CAPTRUST FINANCIAL ADVISORS CAPTRUST FINANCIAL ADVISORS

PVCTPVCT
10 quarters

Position history for CAPTRUST FINANCIAL ADVISORSCAPTRUST FINANCIAL ADVISORS's holdings in PROVECTUS BIOPHARMACEUTICALS

CAPTRUST FINANCIAL ADVISORS previously held 0 shares of PVCT (PROVECTUS BIOPHARMACEUTICALS), worth $0 as of 2022-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$1,000

Total Shares Change

-21,657

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q3
Latest
Exited
0
-100.0%
$00.0%$0.05
0
2022-Q2
Unchanged
20,402
0.0%
$1,0000.0%$0.05
0
2022-Q1
Decreased
20,402
-52.2%
$1,0000.0%$0.06
0
2021-Q4
Increased
42,659
+90.0%
$2,0000.0%$0.06
12
2021-Q3
Unchanged
22,457
0.0%
$1,0000.0%$0.06
0
2021-Q2
Unchanged
22,457
0.0%
$2,0000.0%$0.07
0
2021-Q1
Unchanged
22,457
0.0%
$2,0000.0%$0.07
0
2020-Q4
New
22,457
-
$1,0000.0%$0.06
17
2020-Q3
Exited
0
-100.0%
$00.0%$0.09
0
2020-Q2
New
21,657
-
$1,0000.0%$0.05
17

Other major holders of PVCT: BLACKROCK ADVISORS LLC, HUNTINGTON NATIONAL BANK

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used